DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

India Glycols Limited — Updates

NSE 3 hrs ago·25 Jul 2026, 6:32 am

India Glycols

India Glycols Limited has shared the web-link of its Annual Report for the financial year 2025-26. This report provides a comprehensive overview of the company's performance during the year. The release of the annual report is a significant event for investors as it offers insights into the company's financial health, growth prospects, and future plans. Investors can use this information to make informed decisions about their investments in India Glycols Limited. Investors should review the annual report to understand the company's progress and outlook. They can also look forward to the company's future announcements and updates to stay informed about its performance.